How Does the AstraZeneca Vaccine Measure Up to Rivals?
In this Motley Fool Live video recorded on March 26, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss whether lesser efficacy versus rivals will hurt the AstraZeneca (NASDAQ: AZN) coronavirus vaccine candidate.
Source Fool.com